Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10805	Companies
233874	Keywords
162571	Articles
124910	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 03/26/2026 at 07:30, 4 months 10 days ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Biophytis SA participated in NVIDIA GTC conference to advance AI-driven drug discovery in longevity in collaboration with LynxKite Technologies and Nebius, positioning them at the forefront of innovation in the $1.5 trillion longevity market

Longevity Biophytis SA AI-driven Drug Discovery NVIDIA GTC Conference LynxKite Technologies
PRESS RELEASE

published on 03/26/2026 at 07:29, 4 months 10 days ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Biophytis announces participation at NVIDIA GTC conference, showcasing AI-driven drug discovery collaborations with LynxKite and Nebius to revolutionize longevity innovation

Biophytis AI-driven Drug Discovery LynxKite NVIDIA GTC Longevity Innovation
BRIEF

published on 03/13/2026 at 07:35, 4 months 23 days ago

Biophytis Unveils Obesity and Sarcopenia Programs at ICFSR Conference

Biophytis Clinical Research Sarcopenia ICFSR Conference Obesity
REGULATED PRESS RELEASE

published on 03/13/2026 at 07:30, 4 months 23 days ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Biophytis presents its development programs in obesity and sarcopenia at the ICFSR conference, showcasing BIO101 in obesity and SARA program in sarcopenia

Biophytis Clinical Research Sarcopenia ICFSR Conference Obesity
PRESS RELEASE

published on 03/13/2026 at 07:29, 4 months 23 days ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Biophytis presents its obesity and sarcopenia development programs at ICFSR Conference, highlighting clinical trials on healthy longevity and innovative therapies

Biophytis Clinical Research Sarcopenia ICFSR Conference Obesity
BRIEF

published on 03/12/2026 at 09:42, 4 months 24 days ago

Biophytis raises €2 million in funding

Biophytis Fundraising Joint Venture Debt Repayment Sarcopenia
PRESS RELEASE

published on 03/12/2026 at 09:37, 4 months 24 days ago

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Biophytis completes a €2.0 million capital increase, repays variable price convertible debt, and plans to focus on clinical development in sarcopenia and obesity. Key investors include Alumni Capital Management, Bigger Capital, and Hexagon Capital Fund

Biophytis Capital Increase Sarcopenia Obesity Convertible Debt
BRIEF

published on 03/12/2026 at 07:35, 4 months 24 days ago

Biophytis Expands AI Partnership with LynxKite for Longevity Drug Discovery

Biophytis Drug Discovery Longevity Sarcopenia LynxKite
REGULATED PRESS RELEASE

published on 03/12/2026 at 07:30, 4 months 24 days ago

Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Biophytis and LynxKite form alliance to boost AI-driven drug discovery for longevity therapies, targeting sarcopenia and AMD

Biophytis Sarcopenia AI-driven Drug Discovery LynxKite Longevity Therapeutics
BRIEF

published on 03/11/2026 at 08:05, 4 months 25 days ago

Biophytis Completes €2.0 Million Capital Increase

Biophytis Clinical Trials Capital Increase Sarcopenia Convertible Debt

Accesswire

Published on 08/06/2026 at 03:35, 1 hour 14 minutes ago

Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 3 hours 9 minutes ago

Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 5 hours 9 minutes ago

Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 5 hours 39 minutes ago

Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 5 hours 48 minutes ago

Full Circle Lithium Announces Extension of Current Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/05/2026 at 23:23, 5 hours 25 minutes ago

EQS-Adhoc: Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Published on 08/05/2026 at 23:04, 5 hours 45 minutes ago

AUTODOC to publish H1 2026 report and host a conference call on Q2 results on 13 August 2026
Published on 08/05/2026 at 19:14, 9 hours 35 minutes ago

2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:45, 10 hours 4 minutes ago

Holding(s) in Company
Published on 08/05/2026 at 18:30, 10 hours 19 minutes ago

Avolta enters Kolkata Airport, growing duty-free presence in India

Les Echos

Published on 08/05/2026 at 18:00, 10 hours 49 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 10 hours 59 minutes ago

Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 11 hours 4 minutes ago

Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 11 hours 4 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/05/2026 at 17:42, 11 hours 7 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 July 2026

View all LES ECHOS COMFI WIRE